Linxin comes from Sichuan, China. She qualified in Medicine at Fudan University, China in 2008, including an elective at the University of British Columbia, Canada. She then started her Neurology training and achieved her Master's degree in Clinical Neurology in 2010. She has joined the Stroke Prevention Research Unit since October 2010 and finished her D.Phil. in Clinical Neurology at Oxford University in January 2014.

• Sloane-Robinson Foundation Graduate Award, Lincoln College, Oxford (2010-2013)
• Young Investigator Award, European Stroke Conference (2014)
• Young Investigator Award, European Stroke Organisation (2016)
• Emerging Aspirin Investigator Science Award, Aspirin Foundation (2017)
• Early Career Researcher Prize, NDCN, Oxford (2018)

My main research project focuses on the aetiological classification of transient ischaemic attack and ischaemic stroke. I'm particularly interested in the risk factor profiles, imaging characteristics, plasma biomarkers and outcomes of patients with strokes of undetermined aetiology - cryptogenic stroke.

The other projects I'm working on include studying the association between blood pressure and cerebral small vessel disease, and the risks and benefits of aspirin.